Literature DB >> 26865034

Swallowing outcomes following primary surgical resection and primary free flap reconstruction for oral and oropharyngeal squamous cell carcinomas: A systematic review.

Stephen Shih-Teng Kao1,2, Micah D J Peters2, Sabapathy Giri Krishnan2,3, Eng Hooi Ooi1,4.   

Abstract

OBJECTIVES/HYPOTHESIS: Dysphagia is still a treatment-related morbidity, despite advances in treatment modalities for oral and oropharyngeal squamous cell carcinoma. This systematic review aimed to analyze the effects of swallowing outcomes of patients with oral or oropharyngeal squamous cell carcinoma treated with primary surgery with primary free flap reconstruction, with or without adjuvant therapy, for patients undergoing treatment with curative intent. STUDY
DESIGN: A comprehensive search strategy was undertaken across MEDLINE, CINAHL, Embase, and Scopus. Gray literature was sought through Cochrane Central Register of Controlled Trials, MedNar, and ProQuest.
METHODS: Studies included patients with oral cavity or oropharyngeal squamous cell carcinoma treated with primary surgery with primary free flap reconstruction. Swallowing function was the primary outcome, evaluated at 6 months or later following surgery. Methodological quality and data extraction was conducted as per the Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instrument and standardized data extraction tool.
RESULTS: Fifteen articles comprising eight cohort studies and seven case series were included. Postoperative radiotherapy and oropharyngeal resections were demonstrated to be associated with increased dysphagia.
CONCLUSION: Advanced tumor-node-metastasis stage and use of adjuvant radiotherapy has been shown to have negative impacts on swallowing function. The majority of patients were able to have gastrostomy tubes removed at 6 months following curative therapy. Larger flap mass for the reconstruction of oral and oropharyngeal defects appeared to improve swallowing outcomes. A protocol for the identification of patients at high and low risk of developing dysphagia is proposed. LEVEL OF EVIDENCE: N/A. Laryngoscope, 126:1572-1580, 2016.
© 2016 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Oral cavity squamous cell carcinoma; dysphagia; free flap reconstruction; oropharyngeal squamous cell carcinoma; systematic review

Mesh:

Year:  2016        PMID: 26865034     DOI: 10.1002/lary.25894

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Young-Hoon Joo; Jae-Keun Cho; Bon Seok Koo; Minsu Kwon; Seong Keun Kwon; Soon Young Kwon; Min-Su Kim; Jeong Kyu Kim; Heejin Kim; Innchul Nam; Jong-Lyel Roh; Young Min Park; Il-Seok Park; Jung Je Park; Sung-Chan Shin; Soon-Hyun Ahn; Seongjun Won; Chang Hwan Ryu; Tae Mi Yoon; Giljoon Lee; Doh Young Lee; Myung-Chul Lee; Joon Kyoo Lee; Jin Choon Lee; Jae-Yol Lim; Jae Won Chang; Jeon Yeob Jang; Man Ki Chung; Yuh-Seok Jung; Jae-Gu Cho; Yoon Seok Choi; Jeong-Seok Choi; Guk Haeng Lee; Phil-Sang Chung
Journal:  Clin Exp Otorhinolaryngol       Date:  2019-02-02       Impact factor: 3.372

2.  Prognostic factors associated with achieving total oral diet after glossectomy with microvascular free tissue transfer reconstruction.

Authors:  Diane W Chen; Tao Wang; Jonathan Shey-Sen Ni; Vlad C Sandulache; Evan M Graboyes; Mitchell Worley; Joshua D Hornig; Judith M Skoner; Terry A Day; Andrew T Huang
Journal:  Oral Oncol       Date:  2019-03-28       Impact factor: 5.337

3.  Treatment trends in oropharyngeal carcinoma: Surgical technology meets the epidemic.

Authors:  T J Gal; Jon A Slezak; Alexandra E Kejner; Quan Chen; Bin Huang
Journal:  Oral Oncol       Date:  2019-08-14       Impact factor: 5.972

4.  Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study.

Authors:  Sadayuki Kawai; Tomoya Yokota; Yusuke Onozawa; Satoshi Hamauchi; Akira Fukutomi; Hirofumi Ogawa; Tsuyoshi Onoe; Tetsuro Onitsuka; Takashi Yurikusa; Akiko Todaka; Takahiro Tsushima; Yukio Yoshida; Yosuke Kito; Keita Mori; Hirofumi Yasui
Journal:  BMC Cancer       Date:  2017-01-17       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.